Obsidian Therapeutics
Edit info- Founded: 2015
- Location: Cambridge, MA
- Employee range: 51-100
- Clinical stage: Clin1
- Therapy area: Advanced melanoma (FT)
- Drug types: ONC
- Lead product: OBX-115
- Funding: 100-500M
obsidiantx.com linkedin.com job board
Business:
Cell & Gene Therapies
Drug notes:
3 programs RD/Clin0 undisclosed
About:
Obsidian Therapeutics is developing tumor infiltrating lymphocyte (TIL) therapies for patients with intractable diseases. Conventional TIL therapies have had some success for cancer patients but are still limited by toxicity concerns caused by concomitant IL2 therapy. Using their proprietary cytoDRIVE platform, Obsidian is engineering cytoTIL therapies to express therapeutic proteins that enhance anti-tumor activity and reduce toxicity. Obsidian’s lead program, cytoTIL15, has been engineered to eliminate the need for concomitant IL2 therapy improving the magnitude and duration of response. cytoTIL15 will enter clinical trials for patients with metastatic melanoma.
Associate Director, IT Operations - Digital Soluti...Associate Director, IT Operati...
Bedford, MA|22 days ago
Senior Scientist, Process Development Senior Scientist, Process Deve...
Bedford, MA|27 days ago
Associate Director, Clinical QualityAssociate Director, Clinical Q...
Cambridge, MA|40 days ago
Medical Director, Melanoma Clinical Lead Medical Director, Melanoma Cli...
Cambridge, MA|55 days ago
Senior Manager, Financial Reporting Senior Manager, Financial Repo...
Cambridge, MA|55 days ago
Senior Scientist/Principal Scientist, Analytical D...Senior Scientist/Principal Sci...
Bedford, MA|73 days ago
Manager/Senior Manager, Quality ControlManager/Senior Manager, Qualit...
Bedford, MA|80 days ago
General Interest Application - Obsidian Talent Com...General Interest Application -...
Cambridge, MA|100+ days ago
© 2026 Work In Biotech LLC
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com
Personal dataTerms of ServicePrivacy PolicyContact: recruit@workinbiotech.com